Customized research for GNPX vs. AMGN!

All in one page research, scroll down. Compare two other stocks.

Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.

Done! Side by Side Research Below for GNPX vs. AMGN.


↗ Join Our Free Email Newsletter.




Your Mobile Phone Number:

Genprex Inc. vs. Amgen, Inc.

Industry Match! Industry of Both GNPX and AMGN:

Health Care/Life Sciences

GNPX
Data Last Updated: More than 1 mo ago

↻  Update Column 1 to Most Recent

Key Statistics

Cap: 6M


P/E: N/A

P/S: N/A

Q P/B: 1.7

Y Rev: -

Q Rev: -

Beta: N/A

GNPX Share Stats

Outstanding Shares

15.60M

Float Shares

12.40M

Percent of Float Short

2.92%

GNPX Insider Stats

Percent Outstanding Insider Ownership

3.9%

Percent Outstanding Institution Ownership

5.38%

GNPX Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

GNPX in Pulse Portal

Stream of Posts

GNPX Symbol Page

Share GNPX Insights

Express Sentiment

'Buy' or 'Sell' GNPX

GNPX Profile

CEO

Mr. J. Rodney Varner

Exchange

Nasdaq

Employees

7.00

About

Genprex, Inc. is a clinical stage gene therapy company, which engages in the development of novel proprietary technology platform for the treatment of cancer. It develops the Oncoprex immunogene therapy which targets the non-small cell lung cancer and other solid tumors....

GNPX Financials

Annual Financials

Income Statement

Revenue

-

Net Income

(12.37M)

Cash Flow Statement

Change in Cash / Investments

8.46M

Balance Sheet

Cash / Investments

8.6M

Short Term Debt

None

Long Term Debt

None

Total Current Assets

8.85M

Total Current Liabilities

387,821

Total Assets

9.27M

Total Liabilities

387,821

Stockholder Equity

8.88M

Quarterly Financials

Income Statement

Q Revenue

-

Q Net Income

(2.38M)

Cash Flow Statement

Q Change in Cash / Investments

(1.95M)

Balance Sheet

Q Cash / Investments

2.55M

Q Short Term Debt

None

Q Long Term Debt

None

Q Total Current Assets

3.61M

Q Total Current Liabilities

537,232

Q Total Assets

4.07M

Q Total Liabilities

537,232

Q Stockholder Equity

3.53M

GNPX Charts

10-Year Chart

GNPX 10-Year Chart

5-Year Chart

GNPX 5-Year Chart

1-Year Chart

GNPX 1-Year Chart

6-Month Chart

GNPX 6-Month Chart

3-Month Chart

GNPX 3-Month Chart

1-Month Chart

GNPX 1-Month Chart

1-Day Chart

GNPX 1-Day Chart

AMGN
Data Last Updated: 2 days ago

↻  Update Column 2 to Most Recent

Key Statistics

Cap: 131.81B


P/E: 17.35

P/S: 5.67

Q P/B: 13.63

Y Rev: 23.26B

Q Rev: 6.16B

Beta: 1.14

AMGN Share Stats

Outstanding Shares

609.94M

Float Shares

588.50M

Percent of Float Short

1.60%

AMGN Insider Stats

Percent Outstanding Insider Ownership

0.49%

Percent Outstanding Institution Ownership

98.24%

AMGN Social Stats

Followers

1

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

AMGN in Pulse Portal

Stream of Posts

AMGN Symbol Page

Share AMGN Insights

Express Sentiment

'Buy' or 'Sell' AMGN

AMGN Profile

CEO

Mr. Robert A. Bradway

Exchange

Nasdaq

Employees

23,400

About

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate,...

AMGN Financials

Annual Financials

Income Statement

Revenue

23.26B

Net Income

7.84B

Cash Flow Statement

Change in Cash / Investments

(908M)

Balance Sheet

Cash / Investments

8.91B

Short Term Debt

140M

Long Term Debt

26.95B

Total Current Assets

18.44B

Total Current Liabilities

12.84B

Total Assets

59.71B

Total Liabilities

50.03B

Stockholder Equity

9.67B

Quarterly Financials

Income Statement

Q Revenue

6.16B

Q Net Income

1.7B

Cash Flow Statement

Q Change in Cash / Investments

(5.38B)

Balance Sheet

Q Cash / Investments

8.91B

Q Short Term Debt

140M

Q Long Term Debt

26.95B

Q Total Current Assets

18.44B

Q Total Current Liabilities

12.84B

Q Total Assets

59.71B

Q Total Liabilities

50.03B

Q Stockholder Equity

9.67B

AMGN Charts

10-Year Chart

AMGN 10-Year Chart

5-Year Chart

AMGN 5-Year Chart

1-Year Chart

AMGN 1-Year Chart

6-Month Chart

AMGN 6-Month Chart

3-Month Chart

AMGN 3-Month Chart

1-Month Chart

AMGN 1-Month Chart

1-Day Chart

AMGN 1-Day Chart

 

 


Research

×
Stock Streams
Global Streams

UserStreamReactionsPulseStreamSpecStreamEchoStream
Stock Streams

Message BoardSpecStream TrendingTrending StocksTV Buzz

IPO Buzz (Pricings)IPO Buzz (Upcoming)Stocks Gapping HigherTrending Public Companies (Top Volume Generators)

Uplisted StocksNew 52-Week Highs (NASDAQ)New 52-Week Highs (NYSE)New 52-Week Highs (AMEX)

Technical IndicatorsUpgradesDowngradesRecent Earnings Surprises

Market Streams

Trending IndustriesETF's by SectorSectors Top to BottomCommodities

Economic IndicatorsStock ExchangesETF Movers
Premarket Streams

NASDAQ Premarket GainersNASDAQ Premarket LosersOverseas MarketsS&P Premarket Gainers & Losers

Morning Earning ReleasesFutures

After Hours Streams

After Hours GainersAfter Hours DeclinersAfter Hours Most ActiveAfter the Bell Earning Releases
Symbol Alert Streams

Market Cap MilestonesAbove Average VolumeCurrent Movers - GainersCurrent Movers - Decliners

Short Squeeze AlertsPrice to Earnings PE AlertsPrice to Sales PS AlertsPrice to Book PB Alerts

Insider Holding AlertsInstitutional Holding AlertsLow Float StocksProfitable or Not

Cash Flow PositiveHigh Beta Volatile Stocks

Media Streams

HeadlinesMedia BuzzEconomic NewsTop Stories
Social Streams

Pulse User 'Buys'Pulse User 'Sells'B/S Today Positive Sentiment MilestonesB/S Today Negative Sentiment Milestones

Stock Follower MilestonesStocks Followed by Users


Streams
Streams
            anon
   anon